- Show all
- Abigail Coursolle
- Alejandra Pavisich
- Alejandra Pavisich
- Alexis Robles-Fradet
- Alicia Emanuel
- Amanda Avery
- Amy Chen
- Andy DiAntonio
- Arielle Linsey
- Brian Brooks
- Candace Gibson
- Carly Myers
- Cassandra LaRose
- Cat Duffy
- Catherine McKee
- Cathren Cohen
- Charlie Blodnieks
- Charly Gilfoil
- Christina Piecora
- Corey Davis
- Dania Douglas
- Daniel Young
- daryln
- David Machledt
- Deanna Hartog
- Elizabeth Edwards
- Elizabeth G. Taylor
- Emma Parker-Newton
- Eskedar Girmash
- Fabiola Carrión
- Georgesula Ziama
- Geron Gadd
- Hannah Eichner
- Hayley Penan
- Héctor Hernández-Delgado
- Ian McDonald
- Jane Perkins
- Jasmine Young
- Jennifer Lav
- Joe McLean
- Kally Xu
- Kasey Nichols
- Kimberly Lewis
- Leonardo Cuello
- lhigashi
- Liz McCaman Taylor
- Madeline Morcelle
- Mara Youdelman
- Margaret Okakpu
- Maya Levin
- Michelle Lilienfeld
- Michelle Yiu
- Miriam Delaney Heard
- Mizue Suito
- Priscilla Huang
- Rachel Holtzman
- Rolonda Donelson
- Sarah Grusin
- Sarah Somers
- Skyler Rosellini
- Susan Berke Fogel
- T. Nancy Lam
- veng
- Wayne Turner
- Zamir M. Brown
- Show all
- 1557
- 50th Anniversary
- Abortion
- ADS Evergreen
- Affordable Care Act
- Automated Decision Making
- Behavioral Health
- Child and Adolescent Health
- CHIP
- Civil Procedure
- Civil Rights
- Coronavirus
- Cost-sharing
- Court Access
- COVID-19 Public Health Emergency
- Data Collection
- Defending Medicaid
- Delivery System Reform
- Demonstrations
- Disability
- Disability Rights
- Doula Care
- Dual Eligible Beneficiaries
- Dually eligible
- Eligibility and Enrollment
- EPSDT
- Exchanges/Marketplaces
- Family Planning
- Federal and State Court Cases
- Foster youth
- HCBS/LTSS
- Health Care Reform
- Health Care Refusals
- Health Disparities
- Health Reform
- Healthcare benefits
- HIV/AIDS and Sexual Health
- Home and Community Based Services
- Immigrant Health
- Language Access
- LGBTQ Health
- Litigation
- Managed Care
- Medi-Cal
- Medicaid
- Medicaid Awareness Month
- Medicaid Awareness Month 2024
- Mental Health
- Nondiscrimination
- Opioid Use Disorder
- Oral Health
- Pregnancy
- Prescription Drugs Marketplace
- Prescription Drugs Medicaid
- Privacy and Confidentiality
- Protect Medicaid 2023
- Public Charge
- Public Health
- Reproductive Health
- Services
- Sexual and Reproductive Health (SRH)
- Sexual Health
- Supreme Court
- Telehealth
- Waivers and Demonstrations
- women's health
- Women's Health
- November 11, 2020
Medicaid External Quality Review: An Updated Overview
Read moreIn 2016, the Centers for Medicare & Medicaid Services (CMS) updated Medicaid managed care regulations for the first time in over a decade. This included several new requirements for the External Quality Review (EQR) process. This issue brief reviews the updated EQR process and points out where States can…
- November 5, 2020
NHeLP Comments on DHS’ Affidavit of Support on Behalf of Immigrants Proposed Rule
Read moreThe National Health Law Program submited comments in response to proposed changes to the Department of Homeland Security (DHS) Notice of Proposed Rulemaking, "Affidavit of Support on Behalf of Immigrants.” NHeLP strongly opposed the proposed changes to the Affidavit of Support regulations. If implemented, the policy will increase costs,…
- October 19, 2020
What Public Charge Means for Reproductive Justice
Read moreUpdate: As of March 9, 2021, the Trump-era public charge regulations are no longer in effect. The Biden administration published a final rule on March 15, 2021 formally removing the Trump-era public charge rule and restoring the long-standing 1999 Field Guidance as the standing public charge policy. The administration has significant work…
- October 13, 2020
NHeLP response to HHS Request for Information on Guidance Documents
Read moreHHS posted an undated Request for Information (RFI) on its website asking for input on which guidance documents should undergo notice and comment. In this response, NHeLP object to HHSposting the RFI while a formal rulemaking on the same issue is pending. See NHeLP Comments on HHS Proposed Rule…
- September 17, 2020
NHeLP comments on Approved Drug Products with Therapeutic Equivalence Evaluations (the “Orange Book”)
Read moreThe Orange Book is an important and informative drug resource for a range of stakeholders. In a request for comments, FDA seeks feedback on the types of people or entitles using the Orange Book, additional information and features to incorporate into the Orange Book, and therapeutic equivalence information. NHeLP…
- September 14, 2020
NHeLP comments on HHS Proposed Rule on Guidance
Read moreGuidance documents are a valuable tool that allows agencies to clarify policy issues and explain ambiguities raised by the laws and rules they are tasked with implementing. Programs like Medicaid and the implementation of the Affordable Care Act depend heavily on guidance documents to clarify coverage requirements and the…